Real-time enrollment status for this metastatic biliary tract cancer clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 11:20 PM UTC
| NCT Number | NCT06548412 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Biliary Tract Cancer |
| Phase | PHASE1 |
| Target Enrollment | 50 participants |
| Active Locations | 1 sites in the US |
| Sponsor | M.D. Anderson Cancer Center |
| Last Updated on CT.gov | July 16, 2026 (Yesterday) |
As of July 17, 2026: Clinical trial NCT06548412 is currently recruiting participants. This phase1 study for metastatic biliary tract cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by M.D. Anderson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06548412 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06548412 was last updated Yesterday (July 16, 2026). HelloStudys verifies this status automatically.